Parliamentary Search

Written question asked by Lord Alton of Liverpool (Crossbench), in the House of Lords. It was answered by Earl Howe (Conservative) on Wednesday, 28 July 2010.

Abortion

Question
To ask Her Majesty’s Government how many women aged (a) 14 to 16, (b) 17 to 21, (c) 22 to 24, (d) 25 to 30, (e) 31 to 35, and (f) 36 to 40, in eachregion after taking mifepristone, experienced (1) excessive bleeding, (2) haemorrhaging when the foetus was expelled from the uterus, (3) damage to the cervix, and (4) an infection, in each of the last five years for which figures are available, broken down by length of gestation of the pregnancy.
Answer

This information is shown in the following table.

Total complications reported¹ for abortions using Mifepristone (Mifegyne, RU486) by gestation and age, residents, England & Wales, 2005-2009
Haemorrhage ² Other Complications ³
Gestation
Total abortions using RU486 Total complications 4 under 13 weeks 13 weeks + all gestations
2005 44,779 129 81 31 17
2006 56,805 136 98 24 14
2007 67,917 183 121 30 32
2008 73,472 165 122 43 -
2009 75,045 160 112 25 23
Haemorrhage ² Other Complications ³
Total abortions using RU486 Total complications 4 age under 25 years 25 years + all ages
2005 44,779 129 52 60 17
2006 56,805 136 49 73 14
2007 67,917 183 72 79 32
2008 73,472 165 65 100 -
2009 75,045 160 59 78 23

"Notes: Suppressed value less than 10 (between 0 and 9).""Further breakdown by age and region is not possible due to small numbers. This is in line with the Office for National Statistics' guidance on the disclosure of abortion statistics (2005).""¹ up until the time of discharge from the place of termination.""² Haemorrhage total in 2008 includes suppressed total for ““other complications””.""³ includes uterine perforation and/or sepsis.""4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "Further breakdown by age and region is not possible due to small numbers. This is in line with the Office for National Statistics' guidance on the disclosure of abortion statistics (2005).""¹ up until the time of discharge from the place of termination.""² Haemorrhage total in 2008 includes suppressed total for ““other complications””.""³ includes uterine perforation and/or sepsis.""4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "¹ up until the time of discharge from the place of termination.""² Haemorrhage total in 2008 includes suppressed total for ““other complications””.""³ includes uterine perforation and/or sepsis.""4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "² Haemorrhage total in 2008 includes suppressed total for ““other complications””.""³ includes uterine perforation and/or sepsis.""4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "³ includes uterine perforation and/or sepsis.""4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "4 there may be more than one complication recorded for an abortion.""Source: Information collected from Abortion Notification form HSA4." "Source: Information collected from Abortion Notification form HSA4."

Secondary information

Type
Written question
Reference
1600; 720 c353-4WA
Session
2010-12
Subjects
Abortion Drugs Side effects
Link
View this Written question on www.publications.parliament.uk